• In recent days, Waters Corporation has drawn attention as analysts flagged the company as a potential earnings-beat candidate for its March 2026 quarter, citing expectations of higher revenue and a history of outperforming estimates ahead of its 5 May 2026 report.
• Investor interest has also been reinforced by third-party valuation models suggesting the shares may be undervalued, insider purchases totaling about US$0.5 million in the past three months, and a substantial passive holding of 7,351,785 shares reported by Vanguard Capital Management.
• We’ll now examine how expectations of another earnings beat, combined with perceived undervaluation, may influence Waters’ existing investment narrative.

The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Waters Investment Narrative Recap

To own Waters, you need to believe its core analytical instruments and services can keep earning solid returns while it integrates BD’s Biosciences and Diagnostic Solutions business and manages funding softness in pharma, academic, and government labs. The latest expectation of a possible earnings beat and perceptions of undervaluation may influence short term sentiment, but they do not materially change the key near term catalyst of the BD deal closing smoothly or the main risk that integration and synergy targets fall short.

Among recent developments, the GuruFocus view that Waters shares look undervalued, combined with insider buying of about US$0.5 million, ties most directly to the narrative that earnings could surprise to the upside. If upcoming results on 5 May 2026 reinforce that the underlying business is holding up while the BD combination moves forward, that could strengthen confidence in the company’s ability to manage integration risk and support the case for long term earnings growth.

Yet while short term optimism around an earnings beat is encouraging, investors should be aware that...

Waters' narrative projects $7.5 billion revenue and $1.4 billion earnings by 2029.

Uncover how Waters' forecasts yield a $393.14 fair value, a 28% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts already expected revenue to reach about US$8.3 billion and earnings US$1.5 billion by 2029, and now, with earnings beat talk and questions about Waters’ dependence on aging core technologies, you can see how sharply opinions differ and why it is worth weighing several possible paths from here.

Explore 2 other fair value estimates on Waters - why the stock might be worth as much as 43% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Waters research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Waters research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Waters' overall financial health at a glance.

No Opportunity In Waters?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Capitalize on the AI infrastructure supercycle with our selection of the 37 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.